NCT01538511 - Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 5, 2006

Primary Completion Date

March 13, 2007

Study Completion Date

March 13, 2007

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart 70

Administered subcutaneously (s.c., under the skin) three times daily immediately before breakfast, lunch and dinner for 4 weeks. Dose individually adjusted

DRUG

biphasic insulin aspart 30

Administered subcutaneously (s.c., under the skin) twice daily immediately before breakfast and dinner for 4 weeks. Dose individually adjusted

Trial Locations (1)

1000005

Novo Nordisk Investigational Site, Tokyo